<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04301258</url>
  </required_header>
  <id_info>
    <org_study_id>REG-PRO-002</org_study_id>
    <nct_id>NCT04301258</nct_id>
  </id_info>
  <brief_title>ProChondrix® CR Articular Cartilage Restoration Evaluation (PACE) Registry</brief_title>
  <official_title>ProChondrix® CR Articular Cartilage Restoration Evaluation (PACE) Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AlloSource</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>AlloSource</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this registry is to obtain long-term outcomes on ProChondrix CR in
      cartilage repair procedures of the knee, ankle, foot and hip.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This multi-center, observational registry will be used to evaluate the effectiveness of
      ProChondrix CR in patients who undergo treatment for an articular cartilage defect in the
      knee, ankle, foot or hip.

      This registry will be performed at up to 30 clinical sites across the United States.

      Patient follow-up will occur following an articular cartilage repair procedure in which the
      patient receives ProChondrix CR. During this follow-up period, each patient will be evaluated
      at least four (4) times at: 3, 6, 12 and 24 months after surgical intervention and will
      continue annually for as long as patients are willing to fill out questionnaires and outcomes
      assessments up to 10 years post operatively.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 6, 2020</start_date>
  <completion_date type="Anticipated">December 2040</completion_date>
  <primary_completion_date type="Anticipated">December 2040</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <target_duration>10 Years</target_duration>
  <primary_outcome>
    <measure>Long-Term Outcomes of ProChondrix CR</measure>
    <time_frame>10 Years Post-Operative</time_frame>
    <description>Obtain long-term results on patients who have undergone an articular cartilage repair procedure using ProChondrix CR, as assessed by patient reported outcomes.</description>
  </primary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Cartilage Injury</condition>
  <condition>Cartilage Damage</condition>
  <arm_group>
    <arm_group_label>Articular Cartilage Defect of the Knee</arm_group_label>
    <description>Patients, who undergo an articular cartilage repair of the knee using ProChondrix CR.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Articular Cartilage Defect of the Ankle</arm_group_label>
    <description>Patients, who undergo an articular cartilage repair of the ankle using ProChondrix CR.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Articular Cartilage Defect of the Foot</arm_group_label>
    <description>Patients, who undergo an articular cartilage repair of the foot using ProChondrix CR.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Articular Cartilage Defect of the Hip</arm_group_label>
    <description>Patients, who undergo an articular cartilage repair of the hip using ProChondrix CR.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Articular cartilage repair</intervention_name>
    <description>Patient reported outcomes will be collected on patients who have had a cartilage repair procedure using ProChondrix CR in the knee, hip, foot or ankle.</description>
    <arm_group_label>Articular Cartilage Defect of the Ankle</arm_group_label>
    <arm_group_label>Articular Cartilage Defect of the Foot</arm_group_label>
    <arm_group_label>Articular Cartilage Defect of the Hip</arm_group_label>
    <arm_group_label>Articular Cartilage Defect of the Knee</arm_group_label>
    <other_name>ProChondrix CR</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients, who diagnosed by their treating physician, have a cartilage defect in the knee,
        ankle, foot or hip that requires surgical intervention utilizing ProChondrix CR.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosed by physician to have a cartilage defect in the knee, ankle, foot or hip that
             requires surgical intervention;

          -  Will be having, or has had, a cartilage repair procedure using ProChondrix CR;

          -  Has the ability to understand the requirements of the registry, to provide written
             informed consent and to comply with the registry protocol;

        Exclusion Criteria:

        • Is a ward of the state, prisoner, or transient.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jill Bagdasarian</last_name>
    <role>Study Director</role>
    <affiliation>AlloSource</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jeanine Bailey</last_name>
    <phone>720-873-4811</phone>
    <email>jbailey@allosource.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jill Bagdasarian</last_name>
    <phone>720-382-2742</phone>
    <email>jbagdasarian@allosource.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Rocky Mountain Foot and Ankle Center</name>
      <address>
        <city>Wheat Ridge</city>
        <state>Colorado</state>
        <zip>80033</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brett Sachs, DPM, FACFAS</last_name>
      <phone>303-423-2520</phone>
    </contact>
    <investigator>
      <last_name>Brett Sachs, DPM, FACFAS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Beacon Orthopaedics &amp; Sports Medicine</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45247</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Argo</last_name>
      <phone>888-773-4353</phone>
      <email>dargo@beaconortho.com</email>
    </contact>
    <contact_backup>
      <last_name>Daniele Schum</last_name>
      <phone>513-354-7796</phone>
      <email>dschum@beaconortho.com</email>
    </contact_backup>
    <investigator>
      <last_name>David Argo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>March 6, 2020</study_first_submitted>
  <study_first_submitted_qc>March 6, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 10, 2020</study_first_posted>
  <last_update_submitted>June 15, 2020</last_update_submitted>
  <last_update_submitted_qc>June 15, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 16, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cartilage</keyword>
  <keyword>Cartilage Injury</keyword>
  <keyword>Cartilage Repair</keyword>
  <keyword>Cartilage Damage</keyword>
  <keyword>Cartilage Lesion</keyword>
  <keyword>Cartilage Defect</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

